Trial Profile
Valsartan vs olmesartan medoxomil in patients with essential hypertension despite treatment with amlodipine + hydrochlorothiazide
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2012
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Hydrochlorothiazide (Primary) ; Olmesartan medoxomil (Primary) ; Valsartan
- Indications Essential hypertension
- Focus Therapeutic Use
- 22 May 2012 Results presented at the 27th Annual Scientific Meeting of the American Society of Hypertension.
- 15 May 2012 New trial record
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.